The embryology and molecular-genetic mechanisms of brain tumor pathogenesis: literature review
DOI:
https://doi.org/10.25305/unj.57744Keywords:
brain, cancer, molecular-genetic changes, individualization of treatmentAbstract
The literature review describes molecular-genetic changes in adults and children’s brain tumors which are diagnosed most often. The results of the published data show considerable heterogeneity and differences of these changes depending on the type of a tumor, period of research, and the age of patients. Identification of dominant molecular rearrangements in a particular patient at a certain stage of carcinogenesis helps customize the selection and enhance the effect of treatment by determining the priority of potential targets for differentiated influence.
References
1. Louis DN. A molecular genetic model of astrocytoma histopathology. Brain Pathol. 1997 Apr;7(2):755-64. [CrossRef] [PubMed]
2. Khominskiy BS.Opukholi tsentralnoy nervnoy sistemy [Tumors of the central nervous system]. In: Khominskiy BS, editor. Mnogotomnoye rukovodstvo po patologicheskoy anatomii. Patologicheskaya anatomiya nervnoy sistemy [Many volumes guide to pathological anatomy. Pathological anatomy of the nervous system]. Moscow; 1962;2. p.376-559. Russian.
3. Collins VP. Brain tumours: classification and genes. J Neurol Neurosurg Psychiatry. 2004 Jun;75 Suppl 2:ii2-11. [CrossRef] [PubMed]
4. Skoromets AA, editor. Molekulyarnaya nevrologiya. Opukholi golovnogo mozga, onkogeny i antionkogeny [Brain tumors, oncogenes and antioncogenes]. St. Petersburg: Intermedika: 2004:3. Russian.
5. Repin VS, Sukhikh GT. Meditsinskaya kletochnaya biologiya [Medical Cell Biology]. Moscow: BEBiM; 1998. Russian.
6. Tsymbalyuk VI, Medevedev VV. Neyrogennyye stvolovyye kletki [Neurogenic stem cells]. Kiev: Koval, 2005. Russian.
7. Konopka G, Bonni A. Signaling pathways regulating gliomagenesis. Curr Mol Med. 2003 Feb;3(1):73-84. [CrossRef] [PubMed]
8. Ueda R, Yoshida K, Kawakami Y, Kawase T, Toda M. Immunohistochemical analysis of SOX6 expression in human brain tumors. Brain Tumor Pathol. 2004;21(3):117-20. [CrossRef] [PubMed]
9. Sadler TV. Medychna embriolohiya za Lanhmanom [Medical embryology by Lanhman]. Lviv: Nautylus; 2001. Ukrainian.
10. Tief K, Schmidt A, Aguzzi A, Beermann F. Tyrosinase is a new marker for cell populations in the mouse neural tube. Dev Dyn. 1996 Apr;205(4):445-56. [CrossRef] [PubMed]
11. Rao Y, Wu JY. Neuronal migration and the evolution of the human brain. Nat Neurosci. 2001 Sep;4(9):860-2. [CrossRef] [PubMed]
12. Gilyarov AV. [Nestin in the cells of the central nervous system]. Morfologiya. 2007;131(1):85-90. Russian. [PubMed]
13. Pattyn A, Goridis C, Brunet JF. Specification of the central noradrenergic phenotype by the homeobox gene Phox2b. Mol Cell Neurosci. 2000 Mar;15(3):235-43. [PubMed]
14. Schonemann MD, Ryan AK, McEvilly RJ, OConnell SM, Arias CA, Kalla KA, Li P, Sawchenko PE, Rosenfeld MG. Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev. 1995 Dec 15;9(24):3122-35. [CrossRef] [PubMed]
15. Campbell K, Götz M. Radial glia: multi-purpose cells for vertebrate brain development. Trends Neurosci. 2002 May;25(5):235-8. [CrossRef] [PubMed]
16. Merkle FT, Tramontin AD, Garcia-Verdugo JM, Alvarez-Buylla A. Radial glia give riseto adult neural stem cells in the subventricular zone. Proc. Natl. Acad. Sci. USA. 2004;101(50):17528-32. [CrossRef] [PubMed]
17. Rakic P. Development alandevolutionary adaptations of cortical radial glia. Cereb Cortex. 2003;13(6):541-9. [CrossRef] [PubMed]
18. Louis DN, Ohgaki H, Wiestler OD, Cavenee WKJ, editors. WHO Classification of Tumours of the Central Nervous System. Lyon: IARC; 2007.
19. Peters N, Waha A, Wellenreuther R, Friedrich RE, Mautner VF, Hoffmeyer S, Lenartz D, Schramm J, Wiestler OD, von Deimling A. Quantitative analysis of NF1 and OMGP gene transcripts in sporadic gliomas, sporadic meningiomas and neurofibromatosis type 1-associated plexiform neurofibromas. Acta Neuropathol. 1999 Jun;97(6):547-51. [CrossRef] [PubMed]
20. Wiestler OD, Radner H. Pathology of Neurofibromatosis 1 and 2. In: Huson SM, Hughes RAC, editors. The Neurofibromatoses. A pathogenetic and clinical overview. London; New York; Tokyo; Melbourne: Chapman&Hall Medical, 1993. P.135–159.
21. Neumann HP, Eggert HR, Scheremet R [et al.]. Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiat. 1992;55(10):898-901. [CrossRef]
22. Neumann HP, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet. 1991 May 4;337(8749):1052-4. [CrossRef] [PubMed]
23. Wolf HK, Normann S, Green AJ, von Bakel I, Blümcke I, Pietsch T, Wiestler OD, von Deimling A. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions. Acta Neuropathol. 1997 Jan;93(1):93-6. [PubMed]
24. Przkora R, Falkai P, von Deimling A, Wiestler OD, Albus M, Rietschel M, Maier W, Bayer TA. Analysis of a polymorphism in the tuberous sclerosis (TSC2) gene does not predispose to schizophrenia. Eur Arch Psychiatry Clin Neurosci. 1998;248(6):314-5. [CrossRef] [PubMed]
25. Von Deimling A, Louis DN, Schramm J, Wiestler OD. Astrocytic gliomas: characterization on a molecular genetic basis. In: Wiestler OD, Schlegel U, Schramm J, editors. Molecular neuro-oncology and its impact on the clinical management of brain tumors. Berlin; Heidelberg; New York; London; Paris; Tokyo: Springer Verlag. Recent Results in Cancer Research; 1994;135. p.33-42.
26. Wiestler OD. The molecular and genetic basis of neurological disease. Book Review. Brain Pathol. 1993;3:431-2.
27. Pietsch T, Koch A, Wiestler OD. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13. Klin Padiatr. 1997 Jul-Aug;209(4):150-5. [CrossRef] [PubMed]
28. Kitange GJ, Templeton KL, Jenkins RB. Recent advances in the molecular genetics of primary gliomas. Curr Opin Oncol. 2003 May;15(3):197-203. [CrossRef] [PubMed]
29. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 2002 Jan 24;415(6870):436-42. [PubMed]
30. Zhu Y, Parada LF. The molecular and genetic basis of neurological tumours. Nat Rev Cancer. 2002 Aug;2(8):616-26. [CrossRef] [PubMed]
31. Palma L, Mastronardi L, Celli P, dAddetta R. Cavernous angioma associated with oligo-astrocytoma-like proliferation. Report of two cases and review of the literature with a reappraisal of the term "angioglioma". Acta Neurochir (Wien). 1995;133(3-4):169-73. [CrossRef] [PubMed]
32. Whittle IR, Dow GR, Lammie GA, Wardlaw J. Dsyembryoplastic neuroepithelial tumour with discrete bilateral multifocality: further evidence for a germinal origin. Br J Neurosurg. 1999 Oct;13(5):508-11. [CrossRef] [PubMed]
33. Kogan YeA. Morfologicheskaya kharakteristika, morfogenez i gistogenez opukholey [Morphological characteristics, morphogenesis and histogenesis of tumors]. In: Serov VV, Paltsev MA, editors. Patologicheskaya anatomiya: kurs lektsiy [Pathology: lectures]. Moscow: Meditsina; 1998. p.247-62. Russian.
34. Kogan YeA. Opukholevyy rost [Tumor growth]. In: Serov VV, Paltsev MA, editors. Patologicheskaya anatomiya: kurs lektsiy [Pathology: lectures]. Moscow: Meditsina; 1998. p.224-47. Russian.
35. Grigoriyev DG. Izbrannyye voprosy onkomorfologii [Selected questions oncomorphology]. In: Kravtsova GI, editor. Sbornik naucykh rabot [Collection of scientific works]. Minsk; 2000. p.45-53. Russian.
36. Grigoriyev DG. Patomorfologiya redkikh neyroepitelialnykh opukholey TSNS: monografiya [Pathology rare neuroepithelial tumors of the central nervous system: a monograph]. Minsk: BGMU;2005. Russian.
37. Nikiforov BM. Osobennosti opukholey golovnogo mozga u detey [Features of brain tumors in children]. Neyrokhirurgiya i nevrologiya detskogo vozrasta. 2002(1):21-7. Russian.
38. Gorbunova VN, Khachatryan VA. Genetika kantserogeneza i molekulyarnaya etiologiya opukholey golovnogo mozga u detey [The genetics of carcinogenesis and molecular etiology of brain tumors in children]. Neyrokhirurgiya i nevrologiya detskogo vozrasta. 2006(2-3):88-9. Russian.
39. Kogerman P, Grimm T, Kogerman L, Krause D, Undén AB, Sandstedt B, Toftgård R, Zaphiropoulos PG. Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1. Nat Cell Biol. 1999 Sep;1(5):312-9. [PubMed]
40. Smyth I, Narang MA, Evans T, Heimann C, Nakamura Y, Chenevix-Trench G, Pietsch T, Wicking C, Wainwright BJ. Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32. Hum Mol Genet. 1999 Feb;8(2):291-7. [CrossRef] [PubMed]
41. Taylor MD, Gokgoz N, Andrulis IL, Mainprize TG, Drake JM, Rutka JT. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am J Hum Genet. 2000 Apr;66(4):1403-6. [CrossRef] [PubMed]
42. Avigad S, Barel D, Blau O, Malka A, Zoldan M, Mor C, Fogel M, Cohen IJ, Stark B, Goshen Y, Stein J, Zaizov R. A novel germ line p53 mutation in intron 6 in diverse childhood malignancies. Oncogene. 1997 Apr 3;14(13):1541-5. [CrossRef] [PubMed]
43. Levine AJ, Schmidek HH, editors. Molecular genetic of the nervous system tumors. New York: John Wiley & Sons; 1993.
44. Pietsch T, Wiestler OD. Molecular neuropathology of astrocytic brain tumors. J Neurooncol. 1997 Dec;35(3):211-22. [PubMed]
45. Wiestler OD, von Deimling AA. Model for the molecular pathogenesis of astrocyticgliomas. In: Nagai M, editor. Brain tumor research and therapy. Berlin; Heidelberg; New York; London; Paris; Tokyo: Springer Verlag; 1995. p.173-86.
46. Schlegel U, Neumann J, Kindermann D. [et al.]. Prognostic relevance of transforming genes. In: Wiestler OD, Schlegel U, Schramm J, editors. Molecular neuro-oncology and its impact on the clinical management of brain tumors. Berlin; Heidelberg; New York; London; Paris; Tokyo:Springer Verlag, Recent Results in Cancer Research; 1994;135. p.43-53.
47. Goussia AC, Kyritsis AP, Mitlianga P, Bruner JM. Genetic abnormalities in oligodendroglial and ependymal tumours. J Neurol. 2001 Dec;248(12):1030-5. [CrossRef] [PubMed]
48. Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T, von Deimling A. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol. 1999 Aug;155(2):627-32. [CrossRef] [PubMed]
49. Trunin IuIu. [Comprehensive approach to treating cranial ependymomas in children]. Zh Vopr Neirokhir Im N N Burdenko. 2007 Jul-Sep;(3):40-7. Russian. [PubMed]
50. Ohgaki H, Eibl RH, Schwab M, Reichel MB, Mariani L, Gehring M, Petersen I, Höll T, Wiestler OD, Kleihues P. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog. 1993;8(2):74-80. [CrossRef] [PubMed]
51. Sager R. Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci USA. 1997 Feb 4;94(3):952-5. [CrossRef] [PubMed]
52. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res. 1997 Oct 1;57(19):4187-90. [PubMed]
53. Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, Seligson D, Kremen TJ, Palotie A, Liau LM, Cloughesy TF, Nelson SF. Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene. 2003 Apr 17;22(15):2361-73. [CrossRef] [PubMed]
54. Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, Mischel PS, Nelson SF. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene. 2003 Jul 31;22(31):4918-23. [PubMed]
61. Koul D. PTEN signaling pathways in glioblastoma. Cancer Biol Ther. 2008 Sep;7(9):1321-5. [CrossRef] [PubMed]
62. Chu EC, Tarnawski AS. PTEN regulatory functions in tumor suppression and cell biology. Med Sci Monit. 2004 Oct;10(10):RA235-41. [PubMed]
63. Ma J, Sawai H, Matsuo Y, Ochi N, Yasuda A, Takahashi H, Wakasugi T, Funahashi H, Sato M, Takeyama H. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells. J Surg Res. 2010 May 1;160(1):90-101. [CrossRef] [PubMed]
64. ELi L, Dutra A, Pak E, Labrie JE 3rd, Gerstein RM, Pandolfi PP, Recht LD, Ross AH. GFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neuro Oncol. 2009 Feb;11(1):9-21. [CrossRef] [PubMed]
65. Kopnin BP. Molekulyarnyye mekhanizmy kantserogeneza [Molecular mechanisms of carcinogenesis]. In: Davydov MI, editor. Entsiklopediya klinicheskoy onkologii [Encyclopedia of Clinical Oncology]. Moscow: RLS-Press; 2004. Russian.
66. Condorelli DF, DellAlbani P, Corsaro M, Giuffrida R, Caruso A, Trovato Salinaro A, Spinella F, Nicoletti F, Albanese V, Giuffrida Stella AM. Metabotropic glutamate receptor expression in cultured rat astrocytes and human gliomas. Neurochem Res. 1997 Sep;22(9):1127-33. [PubMed]
67. Horie M, Okutomi K, Taniguchi Y, Ohbuchi Y, Suzuki M, Takahashi E. Isolation and characterization of a new member of the human Ly6 gene family (LY6H). Genomics. 1998 Nov 1;53(3):365-8. [CrossRef] [PubMed]
68. Przedborski S, Goldman S, Schiffmann SN, Vierendeels G, Depierreux M, Levivier M, Hildebrand J, Vanderhaeghen JJ. Neuropeptide Y, somatostatin, and cholecystokinin neurone preservation in anaplastic astrocytomas. Acta Neuropathol. 1988;76(5):507-10. [CrossRef] [PubMed]
69. Lopes MB, Altermatt HJ, Scheithauer BW, Shepherd CW, VandenBerg SR. Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathol. 1996;91(4):368-75. [PubMed]
70. Kaufmann R, Schöneberg T, Lindschau C, Haller H, Ott T. Cholecystokinin induced signaling in rat glioma C6 cells. Neuropeptides. 1995 Nov;29(5):251-6. [CrossRef] [PubMed]
71. Kaufmann R, Schafberg H, Zieger M, Henklein P, Nowak G. Protein kinase C is involved in cholecystokinin octapeptide-induced proliferative action in rat glioma C6 cells. Neuropeptides. 1998 Apr;32(2):185-9. [CrossRef] [PubMed]
72. Westphal M, Black PM. Perspectives of cellular and molecular neurosurgery. J Neurooncol. 2004 Nov;70(2):255-69. [PubMed]
73. Schlegel U, Neumann J, Kindermann D. [et al.]. Prognostic relevance of transforming genes. In: Wiestler OD, Schlegel U, Schramm J, editors. Molecular Neuro-Oncology and its Impact on the Clinical Management of Brain Tumors. Berlin; Heidelberg; New York; London; Paris; Tokyo: Springer Verlag, Recent Results in Cancer Research; 1994(135):43-53.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2012 Yuriy Zozulya, Tatyana Malysheva, Volodymyr Rozumenko, Yuriy Orlov, Mikhail Shamaev
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.
